Report AMR

About AMR

The usage of antimicrobials causes bacteria or pathogens to change over time and makes antimicrobial pharmaceuticals less effective. This process is called antimicrobial resistance (AMR). When AMR infections occur and antimicrobials become ineffective, these infections can in the worst cases be fatal. In Japan and overseas, more and more microbes are developing AMR. If the current situation continues unabated, the annual number of deaths due to AMR infections is projected to increase to about 10 million people globally by 2050.
HGPI issued calls for action on this issue and AMR Alliance Japan was established in November 2018 with the goal of driving discussions and promoting policies for AMR with representatives from industry, Government, academia, and civil society. In its role as secretariat of AMR Alliance Japan, HGPI works to formulate policy recommendations and to see those recommendations implemented.

[Activity Report] Recommendations for Creating a Sustainable Innovation Ecosystem for Antimicrobial R&D (August 1, 2023)
2023-09-13

[Activity Report] Recommendations for Creating a Sustainable Innovation Ecosystem for An ...>>

[Announcement] Signs Open Letter Calling for Action at UN High-Level Meeting on Pandemic Prevention, Preparedness and Response (September 12, 2023)
2023-09-12

[Announcement] Signs Open Letter Calling for Action at UN High-Level Meeting on Pandemic ...>>

[Event Report] APEC Workshop “Incentives to Bring New Antibiotics to APEC Markets” (July 31, August 1, 2023)
2023-08-29

[Event Report] APEC Workshop “Incentives to Bring New Antibiotics to APEC Markets” (July ...>>

[In the media] “Tech-powered War on AMR” (BioSpectrum Asia Edition, July 4, 2023)
2023-07-24

[In the media] “Tech-powered War on AMR” (BioSpectrum Asia Edition, July 4, 2023)>>

[In the Media] “AMR Alliance Japan Presents Recommendations for the Basic Policy on Economic and Fiscal Management and Reform to Advance AMR Countermeasures” (June 7, 2023)
2023-06-09

[In the Media] “AMR Alliance Japan Presents Recommendations for the Basic Policy on Econ ...>>

[Policy Recommendation] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2023 (May 24, 2023)
2023-06-07

[Policy Recommendation] Recommendation for the Basic Policy on Economic and Fiscal Manag ...>>

[Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)
2023-05-26

[Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovati ...>>

[Event Report] Recommendations to Prime Minister Fumio Kishida on the issue of antimicrobial resistance (AMR) in the G7 Hiroshima Summit Leaders’ Declaration (April 28, 2023)
2023-05-12

[Event Report] Recommendations to Prime Minister Fumio Kishida on the issue of antimicro ...>>

[Event Report] Special Diet Member Study Session “Examining Prospects for International Collaboration on Antimicrobial Resistance (AMR) Ahead of the G7 Hiroshima Summit” (February 28, 2023)
2023-04-19

[Event Report] Special Diet Member Study Session “Examining Prospects for Internat ...>>

[In the Media] “45.8% of physicians consider antimicrobial drug prices to be “cheap”, and slightly less than 70% of physicians support the introduction of the pull incentives.” (Mix Online, April 4, 2023)
2023-04-11

[In the Media] “45.8% of physicians consider antimicrobial drug prices to be “chea ...>>

[Research Report] “Awareness Survey on Reforming Existing Systems to Achieve Sustainable Antimicrobial Resistance (AMR) Countermeasures: Looking Beyond the COVID-19 Pandemic” Overall Results. (March 31, 2023)
2023-03-31

[Research Report] “Awareness Survey on Reforming Existing Systems to Achieve Susta ...>>

[Event Report] The 8th Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference – Asia Africa Medical Innovation Consortium (AMIC) (March 9, 2023)
2023-03-31

[Event Report] The 8th Meeting of the AMR Consortium of the Nikkei FT Communicable Disea ...>>

PageTop